Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Use of adult mesenchymal stromal cells in tissue repair: impact of physical exercise.

Bourzac C, Bensidhoum M, Pallu S, Portier H.

Am J Physiol Cell Physiol. 2019 Oct 1;317(4):C642-C654. doi: 10.1152/ajpcell.00530.2018. Epub 2019 Jun 26.

PMID:
31241985
2.

Intense bone fluorescence reveals hidden patterns in pumpkin toadlets.

Goutte S, Mason MJ, Antoniazzi MM, Jared C, Merle D, Cazes L, Toledo LF, El-Hafci H, Pallu S, Portier H, Schramm S, Gueriau P, Thoury M.

Sci Rep. 2019 Mar 29;9(1):5388. doi: 10.1038/s41598-019-41959-8.

3.

Quick benefits of interval training versus continuous training on bone: a dual-energy X-ray absorptiometry comparative study.

Boudenot A, Maurel DB, Pallu S, Ingrand I, Boisseau N, Jaffré C, Portier H.

Int J Exp Pathol. 2015 Dec;96(6):370-7. doi: 10.1111/iep.12155. Epub 2016 Jan 11.

4.

Does running strengthen bone?

Boudenot A, Achiou Z, Portier H.

Appl Physiol Nutr Metab. 2015 Dec;40(12):1309-12. doi: 10.1139/apnm-2015-0265. Epub 2015 Sep 28.

PMID:
26562001
5.

Effect of the alcohol consumption on osteocyte cell processes: a molecular imaging study.

Maurel DB, Benaitreau D, Jaffré C, Toumi H, Portier H, Uzbekov R, Pichon C, Benhamou CL, Lespessailles E, Pallu S.

J Cell Mol Med. 2014 Aug;18(8):1680-93. doi: 10.1111/jcmm.12113. Epub 2013 Aug 15.

6.

Bone mineral density, hip bone geometry, and calcaneus trabecular bone texture in obese and normal-weight children.

Rocher E, El Hage R, Chappard C, Portier H, Rochefort GY, Benhamou CL.

J Clin Densitom. 2013 Apr-Jun;16(2):244-9. doi: 10.1016/j.jocd.2013.02.001. Epub 2013 Mar 7.

PMID:
23473958
7.

Lipid peroxidation in judoists using oral contraceptives.

Massart A, Portier H, Rosado F, Toumi H, Filaire E.

Int J Sports Med. 2012 Oct;33(10):781-8. Epub 2012 May 4.

PMID:
22562736
8.

Lecturing to 200 students and its effects on cytokine concentration and salivary markers of adrenal activation.

Filaire E, Larue J, Portier H, Abed A, Graziella PD, Teixeira A, Anne P.

Stress Health. 2011 Apr;27(2):e25-35.

PMID:
27486621
9.

[Nasopharyngeal carriage, antibiotic susceptibility and serotyping of Streptococcus pneumoniae and Haemophilus influenzae in children attending day care centers].

Chavanet P, Atale A, Mahy S, Neuwirth C, Varon E, Dabernat H, Portier H.

Med Mal Infect. 2011 Jun;41(6):307-17. doi: 10.1016/j.medmal.2011.02.001. Epub 2011 Mar 22. French.

PMID:
21429682
10.

Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise.

Filaire E, Massart A, Rouveix M, Portier H, Rosado F, Durand D.

Eur J Appl Physiol. 2011 Aug;111(8):1829-39. doi: 10.1007/s00421-010-1807-x. Epub 2011 Jan 11.

PMID:
21222131
11.

Effect of 6 Weeks of n-3 fatty-acid supplementation on oxidative stress in Judo athletes.

Filaire E, Massart A, Portier H, Rouveix M, Rosado F, Bage AS, Gobert M, Durand D.

Int J Sport Nutr Exerc Metab. 2010 Dec;20(6):496-506.

PMID:
21116022
12.

Effect of lecturing to 200 students on heart rate variability and alpha-amylase activity.

Filaire E, Portier H, Massart A, Ramat L, Teixeira A.

Eur J Appl Physiol. 2010 Mar;108(5):1035-43. doi: 10.1007/s00421-009-1310-4. Epub 2009 Dec 11.

PMID:
20012447
13.

Salbutamol intake and substrate oxidation during submaximal exercise.

Arlettaz A, Le Panse B, Portier H, Lecoq AM, Thomasson R, De Ceaurriz J, Collomp K.

Eur J Appl Physiol. 2009 Jan;105(2):207-13. doi: 10.1007/s00421-008-0891-7. Epub 2008 Oct 17.

PMID:
18925413
14.

Effects of branched-chain amino acids supplementation on physiological and psychological performance during an offshore sailing race.

Portier H, Chatard JC, Filaire E, Jaunet-Devienne MF, Robert A, Guezennec CY.

Eur J Appl Physiol. 2008 Nov;104(5):787-94. doi: 10.1007/s00421-008-0832-5. Epub 2008 Aug 13.

PMID:
18704484
15.

Short-term glucocorticoid intake combined with intense training on performance and hormonal responses.

Collomp K, Arlettaz A, Portier H, Lecoq AM, Le Panse B, Rieth N, De Ceaurriz J.

Br J Sports Med. 2008 Dec;42(12):983-8. Epub 2007 Nov 29.

PMID:
18048433
16.

Effects of short-term prednisolone intake during submaximal exercise.

Arlettaz A, Portier H, Lecoq AM, Rieth N, De Ceaurriz J, Collomp K.

Med Sci Sports Exerc. 2007 Sep;39(9):1672-8.

PMID:
17805102
17.

Effects of acute prednisolone intake on substrate utilization during submaximal exercise.

Arlettaz A, Portier H, Lecoq AM, Labsy Z, de Ceaurriz J, Collomp K.

Int J Sports Med. 2008 Jan;29(1):21-6. Epub 2007 Jul 5.

PMID:
17614029
18.

Effects of acute prednisolone administration on exercise endurance and metabolism.

Arlettaz A, Collomp K, Portier H, Lecoq AM, Rieth N, Le Panse B, De Ceaurriz J.

Br J Sports Med. 2008 Apr;42(4):250-4; discussion 254. Epub 2007 Jul 3.

PMID:
17609220
19.

Efficacy of humanlike Augmentin SR (2000/125 mg) twice daily treatment on Haemophilus influenzae experimental pneumonia in rabbits.

Croisier D, Benoit M, Durand D, Lequeu C, Piroth L, Portier H, Chavanet P.

Scand J Infect Dis. 2007;39(2):115-21.

PMID:
17366027
20.

Limitation of exercise capacity in nucleoside-treated HIV-infected patients with hyperlactataemia.

Duong M, Dumas JP, Buisson M, Martha B, Piroth L, Grappin M, Waldner A, Chavanet P, Portier H.

HIV Med. 2007 Mar;8(2):105-11.

21.

[Vaccination status of Burgundy inhabitants: a survey in various institutions].

Perot A, Kazaz ES, Morgny C, Portier H.

Med Mal Infect. 2007 Apr;37(4):215-21. Epub 2007 Mar 1. French.

PMID:
17336021
22.

Effects of acute salbutamol intake during supramaximal exercise in women.

Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K.

Br J Sports Med. 2007 Jul;41(7):430-4. Epub 2007 Jan 30.

23.

[Pyogenic psoas abscess: six cases and review of the literature].

Audia S, Martha B, Grappin M, Duong M, Buisson M, Couaillier JF, Lorcerie B, Chavanet P, Portier H, Piroth L.

Rev Med Interne. 2006 Nov;27(11):828-35. Epub 2006 Aug 15. Review. French.

PMID:
16959381
24.

Effects of acute prednisolone intake during intense submaximal exercise.

Arlettaz A, Collomp K, Portier H, Lecoq AM, Pelle A, de Ceaurriz J.

Int J Sports Med. 2006 Sep;27(9):673-9.

PMID:
16944396
25.

Performance of a predictive rule to distinguish bacterial and viral meningitis.

Chavanet P, Schaller C, Levy C, Flores-Cordero J, Arens M, Piroth L, Bingen E, Portier H.

J Infect. 2007 Apr;54(4):328-36. Epub 2006 Aug 2.

PMID:
16887191
26.

[Antibiotic prescription and surveillance].

Grappin M, Portier H.

Rev Prat. 2006 May 31;56(10):1119-27. French. No abstract available.

PMID:
16836210
27.

Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy.

Duong M, Petit JM, Martha B, Galland F, Piroth L, Walldner A, Grappin M, Buisson M, Duvillard L, Chavanet P, Portier H.

HIV Clin Trials. 2006 Mar-Apr;7(2):41-7.

PMID:
16798618
28.

Short term salbutamol ingestion and supramaximal exercise in healthy women.

Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K.

Br J Sports Med. 2006 Jul;40(7):627-31. Epub 2006 May 10.

29.

In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.

Martha B, Croisier D, Durand D, Hocquet D, Plesiat P, Piroth L, Portier H, Chavanet P.

Clin Microbiol Infect. 2006 May;12(5):426-32.

30.

Effects of short-term salbutamol ingestion during a Wingate test.

Le Panse B, Collomp K, Portier H, Lecoq AM, Jaffre C, Beaupied H, Richard O, Benhamou L, De Ceaurriz J, Courteix D.

Int J Sports Med. 2005 Sep;26(7):518-23.

PMID:
16195983
31.

Effects of acute salbutamol intake during a Wingate test.

Collomp K, Le Panse B, Portier H, Lecoq AM, Jaffre C, Beaupied H, Richard O, Benhamou L, Courteix D, De Ceaurriz J.

Int J Sports Med. 2005 Sep;26(7):513-7.

PMID:
16195982
32.

Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Gaillat J, Flahault A, deBarbeyrac B, Orfila J, Portier H, Ducroix JP, Bébéar C, Mayaud C.

Eur J Epidemiol. 2005;20(7):643-51.

PMID:
16119439
33.

[Urinary bovine tuberculosis in man].

Poullain J, Watfa J, Martin L, Portier H, Michel F.

Prog Urol. 2005 Jun;15(3):529-31. French.

PMID:
16097166
34.

Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.

Portier H, Brambilla C, Garre M, Paganin F, Poubeau P, Zuck P.

Eur J Clin Microbiol Infect Dis. 2005 Jun;24(6):367-76.

PMID:
15944847
35.

The impact of mechanical ventilation on the moxifloxacin treatment of experimental pneumonia caused by Streptococcus pneumoniae.

Charles PE, Etienne M, Croisier D, Piroth L, Lequeu C, Pugin J, Portier H, Chavanet P.

Crit Care Med. 2005 May;33(5):1029-35.

PMID:
15891332
36.

Low trough plasma concentrations of nevirapine associated with virologic rebounds in HIV-infected patients who switched from protease inhibitors.

Duong M, Buisson M, Peytavin G, Kohli E, Piroth L, Martha B, Grappin M, Chavanet P, Portier H.

Ann Pharmacother. 2005 Apr;39(4):603-9. Epub 2005 Feb 15.

PMID:
15713788
37.

[Preventive antibiotherapy for splenectomized and asplenic patients. Recent recommendations].

Portier H, Beytout J.

Med Mal Infect. 2004 Jun;34 Suppl 1:S67-8. French. No abstract available.

PMID:
15676253
38.

[Invasive Streptococcus pyogenes infections].

Veyssier-Belot C, Lévy-Bruhl D, Carret G, Bouvet A, Portier H; le groupe de travail.

Med Mal Infect. 2004 Jun;34 Suppl 1:S14-6. French. No abstract available.

PMID:
15676234
39.

Influence of positive end-expiratory pressure (PEEP) on histopathological and bacteriological aspects of pneumonia during low tidal volume mechanical ventilation.

Charles PE, Martin L, Etienne M, Croisier D, Piroth L, Lequeu C, Pugin J, Portier H, Chavanet P.

Intensive Care Med. 2004 Dec;30(12):2263-70. Epub 2004 Nov 4.

PMID:
15536527
40.

Usefulness of therapeutic drug monitoring of antiretrovirals in routine clinical practice.

Duong M, Golzi A, Peytavin G, Piroth L, Froidure M, Grappin M, Buisson M, Kohli E, Chavanet P, Portier H.

HIV Clin Trials. 2004 Jul-Aug;5(4):216-23.

PMID:
15472796
41.

Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits.

Etienne M, Croisier D, Charles PE, Lequeu C, Piroth L, Portier H, Drlica K, Chavanet P.

J Infect Dis. 2004 Oct 15;190(8):1472-5. Epub 2004 Sep 8.

PMID:
15378440
42.

Clinical, immunological and virological evolution in patients with CD4 T-cell count above 500/mm3: is there a benefit to treat with highly active antiretroviral therapy (HAART)?

Piroth L, Binquet C, Buisson M, Kohli E, Duong M, Grappin M, Abrahamowicz M, Quantin C, Portier H, Chavanet P.

Eur J Epidemiol. 2004;19(6):597-604.

PMID:
15330134
43.

In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.

Croisier D, Etienne M, Piroth L, Bergoin E, Lequeu C, Portier H, Chavanet P.

J Antimicrob Chemother. 2004 Sep;54(3):640-7. Epub 2004 Aug 18.

PMID:
15317743
44.

Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors.

Petit JM, Duong M, Masson D, Buisson M, Duvillard L, Bour JB, Brindisi MC, Galland F, Guiguet M, Gambert P, Portier H, Vergès B.

Eur J Clin Invest. 2004 Aug;34(8):569-75.

PMID:
15305892
45.

Bilateral facial palsy in a case of leptospirosis.

Maldonado F, Portier H, Kisterman JP.

Scand J Infect Dis. 2004;36(5):386-8.

PMID:
15287387
46.

Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment.

Préau M, Leport C, Salmon-Ceron D, Carrieri P, Portier H, Chene G, Spire B, Choutet P, Raffi F, Morin M.

AIDS Care. 2004 Jul;16(5):649-61.

PMID:
15223534
47.

Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.

Croisier D, Etienne M, Bergoin E, Charles PE, Lequeu C, Piroth L, Portier H, Chavanet P.

Antimicrob Agents Chemother. 2004 May;48(5):1699-707.

48.

Bacterial endocarditis complicating mitral annular calcification: a clinical and echocardiographic study.

Eicher JC, De Nadai L, Soto FX, Falcon-Eicher S, Dobsák P, Zanetta G, Petit JM, Portier H, Louis P, Wolf JE.

J Heart Valve Dis. 2004 Mar;13(2):217-27. Review.

PMID:
15086260
49.

[New strategies for angina case management in France].

Portier H, Grappin M, Chavanet P.

Bull Acad Natl Med. 2003;187(6):1107-16. Review. French.

PMID:
14978871
50.

[Is there an increased risk for cardiovascular disease in HIV-infected patients on antiretroviral therapy?].

Duong M, Cottin Y, Froidure M, Petit JM, Piroth L, Zeller M, L'huillier I, Fargeot A, Mahrousseh M, Chavanet P, Wolf JE, Portier H.

Ann Cardiol Angeiol (Paris). 2003 Nov;52(5):302-7. Review. French.

PMID:
14714344

Supplemental Content

Loading ...
Support Center